WallStreetZenWallStreetZen
Analyst Ranking
Bottom 2%
#4604 out of 4694 analysts
Average Return
-7.97%
Win Rate
44%50 out of 113
Risk vs Reward
Poor
Good

Andrew Cooper's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Change Healthcare IncCHNG
+231.49%$6.86$22.74
2020-03-17 -
2021-03-18
Strong Buy
Caredx IncCDNA
+191.10%$9.66$28.12
2023-08-14 -
2024-08-14
Buy
Natera IncNTRA
+160.20%$48.54$126.30
2023-11-12 -
2024-10-03
Strong Buy
Heska CorpHSKA
+115.68%$115.19$248.44
2020-10-20 -
2021-10-20
Buy
Natera IncNTRA
+79.38%$70.41$126.30
2024-02-19 -
2024-10-03
Buy

Andrew Cooper Analyst Color

Get additional color on Andrew Cooper's coverage of popular stocks

Andrew Cooper's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Thermo Fisher Scientific IncTMO
5Buy$660.00+9.83%Maintains
2 months ago
Natera IncNTRA
5Buy$85.00-32.70%Downgrades
7 months ago
Quidelortho CorpQDEL
12Buy$76.00+74.91%Downgrades
8 months ago
Hologic IncHOLX
9Buy$88.00+11.08%Maintains
8 months ago
Revvity IncRVTY
4Buy$127.00+2.34%Maintains
8 months ago
Danaher CorpDHR
5Buy$270.00-0.19%Maintains
8 months ago
Avantor IncAVTR
11Buy$26.00+3.46%Maintains
8 months ago
Guardant Health IncGH
2Buy$27.00+23.85%Upgrades
a year ago
Lumiradx LtdLMDXF
10Buy$0.80N/AMaintains
a year ago
Caredx IncCDNA
11Buy$12.00N/AUpgrades
a year ago
Myriad Genetics IncMYGN
3Buy$27.00N/AMaintains
2 years ago
Neogenomics IncNEO
8Buy$19.00N/AMaintains
2 years ago
Fulgent Genetics IncFLGT
1Buy$45.00N/AInitiates Coverage On
2 years ago
Haemonetics CorpHAE
6Buy$100.00N/AMaintains
2 years ago
Exact Sciences CorpEXAS
6Buy$60.00N/AMaintains
2 years ago
Veracyte IncVCYT
7Buy$27.00N/AMaintains
2 years ago
Invitae CorpNVTAQ
6HoldN/AN/ADowngrades
2 years ago
Orasure Technologies IncOSUR
5HoldN/AN/ADowngrades
3 years ago
Biora Therapeutics IncBIOR
2HoldN/AN/ADowngrades
3 years ago
Covetrus IncCVET
1Buy$39.00N/AMaintains
4 years ago
Heska CorpHSKA
2Buy$225.00N/AMaintains
4 years ago
Change Healthcare IncCHNG
1Strong Buy$20.00N/AUpgrades
5 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.